Loading clinical trials...

COMPLETEDPhase 3NCT01326026

Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus

This trial is conducted in Europe and the United States of America (USA). The aim of this trial is to compare the efficacy and safety of NN1250 (insulin degludec (IDeg)) once daily in insulin naïve su...

Lead sponsor: Novo Nordisk A/S•27 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events

NCT06893341 · Diabetes, Hyperglycemia, and more

RECRUITING

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight

RECRUITINGNA

Continuous Glucose Monitoring for Women With Gestational Diabetes

NCT06310356 · Gestational Diabetes

RECRUITINGPhase 4

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

NCT06613854 · Type 2 Diabetes Mellitus (T2DM)

RECRUITINGPhase 1

Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes

NCT07535307 · Diabetes Mellitus

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 6, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment222

Start dateMar 2011

Last updatedMar 6, 2017

Condition

Diabetes Diabetes Mellitus, Type 2

Locations shown

Novo Nordisk Investigational Site

Birmingham, Alabama

Novo Nordisk Investigational Site

Huntsville, Alabama

Novo Nordisk Investigational Site

Anaheim, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 6, 2017Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

Continuous Glucose Monitoring for Women With Gestational Diabetes

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes

Trial snapshot

Condition

Locations shown

For caregivers